Condition
BRAF V600E Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 BRAF V600E Mutation clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Switzerland (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Understanding why BRAF V600E colorectal cancer stops responding to targeted therapy
This study tests why metastatic colorectal cancer with a BRAF V600E mutation stops responding to encorafenib and cetuximab, by collecting tissue, blood, and stool samples over time.
-
Using blood and cerebrospinal fluid tests to monitor treatment in BRAF-altered glioma
This study is testing if a new targeted therapy can help people with a specific type of brain tumor by checking their blood and spinal fluid for signs of the tumor during treatment.
Related topics
Quick answers
How many BRAF V600E Mutation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.